Skip to main content
STRIDES PHARMA SCIENCE LIMITED logo

STRIDES PHARMA SCIENCE LIMITED — Investor Relations & Filings

Ticker · STAR ISIN · INE939A01011 LEI · 335800WHFYXUCHR9DD10 BSE.NS Manufacturing
Open in API
Filings indexed 1,204 across all filing types
Latest filing 2020-07-15 AGM Information
Country IN India
Listing BSE.NS STAR

About STRIDES PHARMA SCIENCE LIMITED

https://www.strides.com

Strides Pharma Science Limited is a global pharmaceutical organization focused on the development and manufacture of IP-led niche finished dosage formulations. The company’s product portfolio encompasses a wide range of therapeutic areas, specializing in complex oral solids, softgel capsules, topicals, and liquids. It maintains a significant presence in highly regulated markets, including the United States, Europe, and Australia, while also serving institutional and emerging markets. The company operates multiple manufacturing facilities globally, many of which are approved by major international regulatory agencies such as the USFDA. Strides emphasizes research and development to drive innovation in specialized delivery systems and difficult-to-manufacture products, positioning itself as a key player in the global generic pharmaceutical landscape.

Recent filings

Filing Released Lang Actions
Dividend Updates
AGM Information Classification · 95% confidence The document is a notification to stock exchanges and members about the upcoming Annual General Meeting (AGM) and the record date for the final dividend. It mentions the date and mode of the AGM, dividend details, and that the Annual Report and AGM notice will be shared later. The document does not contain the Annual Report itself or detailed financial data, but rather an announcement about the AGM and dividend-related information. The document length is short (1994 characters), and it states that the Annual Report and Notice will be shared in due course, indicating this is an announcement rather than the report itself. Therefore, this fits the category of AGM Information (AGM-R), as it relates to the AGM details and dividend record date notification.
2020-07-15 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing the USFDA approval for a pharmaceutical product by Strides Pharma Science Limited. It is addressed to stock exchanges and includes contact information for investor relations. The document is short (3784 characters) and does not contain financial statements, detailed financial analysis, or regulatory filings. It is an announcement of a corporate event (product approval) rather than a financial report or regulatory filing. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous announcements that do not fit other categories.
2020-07-09 English
Amalgamation/Merger
M&A Activity Classification · 95% confidence The document is a letter addressed to stock exchanges informing them about the National Company Law Tribunal (NCLT) order sanctioning the merger of wholly owned subsidiaries with the company. It references the approval process of a Scheme of Amalgamation under the Companies Act, 2013. The document is an official announcement of a corporate restructuring event (merger) and does not contain financial statements, audit information, or detailed financial analysis. It is not a full report but an update on a merger approval process. This fits the category of M&A Activity (TAR) as it relates to merger announcements and related regulatory approvals.
2020-06-19 English
Related Party Transactions
Regulatory Filings Classification · 95% confidence The document is a detailed disclosure of related party transactions for the fiscal year ended March 31, 2020, prepared in accordance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It includes comprehensive financial data on transactions with joint ventures, associates, directors, key management personnel, and enterprises significantly influenced by them. The document contains actual financial figures and detailed classifications of transactions such as sales, purchases, loans, reimbursements, and remuneration. It is not a brief announcement or a certification letter but a substantive financial disclosure. Such disclosures are typically part of the financial statements or notes to accounts in annual or interim reports but can also be standalone disclosures required by regulators. Given the detailed financial data and the regulatory reference, this document fits best under Regulatory Filings (RNS) as it is a regulatory compliance disclosure rather than a full annual report or audit report. It is not an earnings release, management report, or any other specific category. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2020-06-18 English
Loss of Share Certificates
Regulatory Filings
2020-06-18 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) regarding the issuance of duplicate share certificates to shareholders. It references Regulation 39 (3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, which pertains to share certificate management. The content is about share certificate issuance and does not contain financial data, earnings, management changes, or meeting materials. It is an announcement related to share certificates but not a capital change or share issue announcement. The document is short (2151 characters) and is an official notification to exchanges for record-keeping and regulatory compliance. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-06-10 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.